Description

Arlevert (cinnarizine, dimengidrinat) tablets №20

Ingredients

Active ingredients: Cinnarizine, Dimenhydrinate

Dosage

Recommended dosage: 1 tablet three times a day.

Indications

Arlevert tablets are indicated for the treatment of vertigo and dizziness associated with Meniere’s disease and other vestibular disorders.

Contraindications

Do not use Arlevert tablets if you are allergic to any of the ingredients, have Parkinson’s disease, or are pregnant.

Directions

Take Arlevert tablets orally with water, preferably after meals to reduce gastrointestinal irritation.

Scientific Evidence

Studies have shown that the combination of cinnarizine and dimenhydrinate in Arlevert tablets effectively reduces vertigo symptoms and improves quality of life in patients with vestibular disorders. Research published in the International Tinnitus Journal demonstrated the efficacy of cinnarizine and dimenhydrinate in managing vertigo symptoms.

Additional Information

It is important to note that Arlevert tablets may cause drowsiness, so it is advisable to avoid driving or operating heavy machinery while taking this medication. Consult your healthcare provider before using Arlevert if you have any underlying medical conditions or are taking other medications.

Pharmacological Effects: Cinnarizine acts as a calcium channel blocker, reducing the excitability of the vestibular system, while dimenhydrinate is an antihistamine that helps alleviate nausea and vomiting associated with vertigo. The combination of these two ingredients in Arlevert tablets provides a synergistic effect in managing vestibular symptoms.

Clinical Trials: A randomized controlled trial published in the Journal of Neurology compared the efficacy of Arlevert tablets with a placebo in patients with Meniere’s disease. The study found that patients receiving Arlevert experienced a significant reduction in vertigo attacks and improved balance compared to the placebo group.